$5.43
-0.16[-2.86%]
At close: May 6
$5.43
0[0.00%]
After Hours: 4:23PM EDT
Prime Medicine
(NASDAQ:PRME)Prime Medicine Stock (NASDAQ:PRME), Quotes and News Summary
Prime Medicine Stock (NASDAQ: PRME) stock price, news, charts, stock research, profile.
| Open | $5.650 |
| Close | $5.400 |
| Volume / Avg. | 1.391M / 754.232K |
| Day Range | 5.390 - 5.770 |
| 52 Wk Range | 4.110 - 17.200 |
| Market Cap | $651.756M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 0 |
| Short Interest | 17.37% |
| Days to Cover | 22.49 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Prime Medicine (PRME) stock?
You can purchase shares of Prime Medicine (NASDAQ: PRME) through any online brokerage.
Who are Prime Medicine's (PRME) competitors?
Other companies in Prime Medicine’s space includes: Cabaletta Bio (NASDAQ:CABA), Cogent Biosciences (NASDAQ:COGT), Pharming (NASDAQ:PHAR), AnaptysBio (NASDAQ:ANAB) and Kyverna Therapeutics (NASDAQ:KYTX).
What is the target price for Prime Medicine (PRME) stock?
The latest price target for Prime Medicine (NASDAQ: PRME) was reported by Wedbush on Tuesday, April 23, 2024. The analyst firm set a price target for 12.00 expecting PRME to rise to within 12 months (a possible 120.99% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Prime Medicine (PRME)?
The stock price for Prime Medicine (NASDAQ: PRME) is $5.43 last updated May 6, 2024 at 4:23 PM EDT.
Does Prime Medicine (PRME) pay a dividend?
A quarterly cash dividend of $0.80 per share of Class A Common Stock. The quarterly cash dividend was payable on September 12, 2019 to stockholders of record on September 10, 2019.
When is Prime Medicine (NASDAQ:PRME) reporting earnings?
Prime Medicine’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Prime Medicine (PRME) going to split?
There is no upcoming split for Prime Medicine.
What sector and industry does Prime Medicine (PRME) operate in?
Prime Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.